文献速递呼吸衰竭与机械通气重症综合管理与镇静镇痛

血浆sRAGE作为脓毒症相关急性呼吸窘迫综合征的遗传调控因果中间体

Plasma sRAGE Acts as a Genetically Regulated Causal Intermediate in Sepsis-associated Acute Respiratory Distress Syndrome.
PubMed 文献 · Am J Respir Crit Care Med · 2020-01-01
一句话结论孟德尔随机化分析提示血浆sRAGE升高可能导致脓毒症相关ARDS风险增加,支持其作为因果中间体。

该研究在三个脓毒症重症队列中测量早期血浆sRAGE并做全基因组基因分型,用孟德尔随机化推断因果。血浆sRAGE与ARDS风险强相关(第一队列OR 1.86,95%CI 1.54-2.25;第二队列OR 2.56,95%CI 2.14-3.06,每log增加)。使用两群体共有的遗传工具,血浆sRAGE对ARDS风险有因果效应,β=0.50(95%CI 0.09-0.91,每log增加)。提示sRAGE在脓毒症相关ARDS中可能作为因果中间体。

要点

  • 两个脓毒症重症队列中,血浆sRAGE每log增加与ARDS风险强相关:第一队列OR 1.86(95%CI 1.54-2.25),第二队列OR 2.56(95%CI 2.14-3.06)。
  • 孟德尔随机化使用两群体共有的遗传工具,血浆sRAGE对ARDS风险的因果效应β=0.50(95%CI 0.09-0.91,每log增加)。
  • 血浆sRAGE在脓毒症期间受遗传调控,MR分析提示其升高导致ARDS风险增加。
  • 作者认为血浆sRAGE可能作为脓毒症相关ARDS的因果中间体。

适用人群与场景

  • 两个脓毒症重症队列:第一队列393例欧洲 ancestry 患者和266例非洲 ancestry 患者,第二队列843例欧洲 ancestry 患者。

研究设计与关键结果

  • 研究类型:孟德尔随机化分析,使用两个脓毒症重症队列的全基因组基因分型和表型数据。
  • 第一队列393例欧洲 ancestry 和266例非洲 ancestry 患者,第二队列843例欧洲 ancestry 患者;测量早期血浆sRAGE。
  • 血浆sRAGE与ARDS风险强相关:第一队列OR 1.86(95%CI 1.54-2.25),第二队列OR 2.56(95%CI 2.14-3.06),每log增加。
  • 使用两群体共有的显著关联变异(P<0.01,R2>0.02)作为遗传工具,逆方差加权法估计因果效应:β=0.50(95%CI 0.09-0.91,每log增加)。

证据类型、等级与局限

  • 证据类型:孟德尔随机化分析(观察性数据因果推断)。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「对床旁实践的改变」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

Rationale: Acute respiratory distress syndrome (ARDS) lacks known causal biomarkers. Plasma concentrations of sRAGE (soluble receptor for advanced glycation end products) strongly associate with ARDS risk. However, whether plasma sRAGE contributes causally to ARDS remains unknown.Objectives: Evaluate plasma sRAGE as a causal intermediate in ARDS by Mendelian randomization (MR), a statistical method to infer causality using observational data.Methods: We measured early plasma sRAGE in two critically ill populations with sepsis. The cohorts were whole-genome genotyped and phenotyped for ARDS. To select validated genetic instruments for MR, we regressed plasma sRAGE on genome-wide genotypes in both cohorts. The causal effect of plasma sRAGE on ARDS was inferred using the top variants with significant associations in both populations (P < 0.01, R2 > 0.02). We applied the inverse variance-weighted method to obtain consistent estimates of the causal effect of plasma sRAGE on ARDS risk.Measurements and Main Results: There were 393 European and 266 African ancestry patients in the first cohort and 843 European ancestry patients in the second cohort. Plasma sRAGE was strongly associated with ARDS risk in both populations (odds ratio, 1.86; 95% confidence interval [1.54-2.25]; 2.56 [2.14-3.06] per log increase). Using genetic instruments common to both populations, plasma sRAGE had a consistent causal effect on ARDS risk with a β estimate of 0.50 (95% confidence interval [0.09-0.91] per log increase).Conclusions: Plasma sRAGE is genetically regulated during sepsis, and MR analysis indicates that increased plasma sRAGE leads to increased ARDS risk, suggesting plasma sRAGE acts as a causal intermediate in sepsis-related ARDS.

来源:Am J Respir Crit Care Med,查看原文。版权归原作者所有。

参考来源

  1. Jones TK, Feng R, Kerchberger VE, et al. Plasma sRAGE Acts as a Genetically Regulated Causal Intermediate in Sepsis-associated Acute Respiratory Distress Syndrome. Am J Respir Crit Care Med. 2020. PMID: 31487195. doi:10.1164/rccm.201810-2033OC

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。